US FDA approves Moderna’s RSV vaccine
- 01-Jun-2024
The US Food and Drug Administration approved Moderna’s respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product. Moderna’s vaccine was approved for the prevention of RSV-associated lower respiratory tract disease in adults aged 60 or older, but with a label indicating the […]
US backs Pfizer’s maternal RSV vaccine to protect infants
- 23-Sep-2023
The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer’s (PFE.N) respiratory syncytial virus (RSV) vaccine for women in the middle of the third trimester of pregnancy to protect their babies from severe illness. The CDC recommendation comes after a panel of advisers voted 11 to 1 for use of the shot […]